Position in RDY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,186,209
-$34,987 QoQ
Shares Held
81,864
-7.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#77
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $5,825,413 across 37 Drug Manufacturers - Specialty & Generic names. RDY ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
25,052 | $1,800,236 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
This page
|
81,864 | $1,186,209 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,130 | $612,267 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
28,293 | $453,536 | |
| 5 | VTRS |
Viatris Inc
|
25,192 | $400,048 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,719 | $289,720 | |
| 7 | PRGO |
PERRIGO Co plc
|
16,056 | $166,821 | |
| 8 | HLN |
Haleon plc
|
16,900 | $157,677 |
All Filings in RDY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,186,209 | 81,864 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,221,196 | 88,173 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $924,421 | 65,842 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,100,226 | 78,700 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,178,953 | 78,440 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $647,167 | 49,065 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,149,354 | 72,790 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,157,745 | 14,572 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $946,432 | 12,422 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $803,329 | 10,952 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $453,244 | 6,514 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $410,381 | 6,137 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $278,567 | 4,414 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $239,618 | 4,209 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $158,613 | 3,065 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $290,539 | 5,551 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $249,033 | 4,496 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $216,120 | 3,878 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $234,429 | 3,584 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $249,746 | 3,834 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $277,647 | 3,777 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $219,592 | 3,577 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $256,929 | 3,604 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $283,317 | 4,073 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $210,767 | 3,976 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $192,414 | 4,771 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||